Classified as a highly advanced, synthetic small molecule inhibitor, this specialized compound is masterfully engineered to target and block the activity of a specific metabolic enzyme known as NNMT (nicotinamide N-methyltransferase)
BPC-157 is not a quick fix, and results are not guaranteed
Serious adverse events have not been widely reported in the community, but the lack of long-term safety data means unknown risks may exist
Just Opened the Door to Twelve More Disseminated on behalf of The Precision Peptide Company SYMBOL | CSE: BPC | OTCQB: PNGAF Outstanding Shares: 47,231,207 Warrants: 8,396,600 Options: 2,733,333 Fully Diluted: 54,699,540 ThePrecisionPeptideCompany.com The Precision Peptide Company (CSE: BPC) is a Vancouver-based natural supplement company that operates in Surrey, British Columbia
Storage: Store between 1C and 3C
Proper medical oversight during administration minimizes these risks